Filtered By:
Specialty: Medical Devices
Countries: Israel Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 27 results found since Jan 2013.
A digital exercise and augmented reality training system improved mobility among stroke patients: A randomized control trial
CONCLUSION: The findings suggest that Selfit holds promise as an effective intervention for improving mobility and gait-related functions among patients with an early sub-acute stroke as compared to conventional physical therapy treatments.PMID:37302046 | DOI:10.3233/THC-220521
Source: Technology and Health Care - June 11, 2023 Category: Medical Devices Authors: Ilanit Evron Oren Schwartz Anna Sajina Liza Grosman-Rimon Israel Dudkiewicz Source Type: research
Viz.ai Raises $50M in Series B round
Viz.ai’s 2019 has been marked with strong adoption of its artificial intelligence software and securing a distribution agreement with one of medtech’s biggest players. The Tel Aviv, Israel and San Francisco-based company’s latest accomplishment is raising $50 million in a series B round.
The financing was led by Greenoaks with participation from Threshold Ventures, CRV along with existing investors GV and Kleiner Perkins.
“This [financing] allows us to get to the next stage,†Dr. Chris Mansi, neurosurgeon, co-founder, and CEO, told MD...
Source: MDDI - October 25, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Baxter to Acquire 1 of the 16 Most Promising Private Companies in Medtech
Baxter Healthcare is set to acquire Cheetah Medical, a firm an analyst identified earlier this year as one of 16 disruptive private companies in medtech.
The transaction consists of an upfront cash consideration of $190 million, with potential for an additional $40 million based on clinical and commercial milestones. It is set to close in 4Q19.
Boston and Tel Aviv, Israel-based Cheetah Medical is a major provider of non-invasive hemodynamic monitoring technologies.
The addition of Cheetah Medical is expected to enhance Deerfield, IL-based Baxter’s presence in the specialized patient monitoring space with ...
Source: MDDI - September 11, 2019 Category: Medical Devices Authors: Omar Ford Tags: IV Products Business Source Type: news
Medtronic and Viz.ai Look to Improve Stroke Outcomes with New Alliance
A collaboration between Viz.ai and Medtronic could lead to better outcomes for stroke patients. Through the distribution agreement, San Francisco, CA-based Viz.ai would increase the reach of its artificial intelligence solution for stroke.
Viz.ai’s solution identifies suspected large vessel occlusion (LVO) strokes and automatically notify specialists. It could lead patients to get treatment by technologies like Dublin-based Medtronic’s Solitaire revascularization device.
“By combining AI software with therapy that works, that’s how we can truly improve...
Source: MDDI - July 23, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Software Source Type: news
ReWalk ’s Momentum Continues with New Nod from FDA
ReWalk Robotics has secured a clearance from FDA for the ReStore soft exo-suit system. The Marlborough, MA and Yokneam Ilit, Israel-based company said exo-suit is intended for use in the treatment of stroke survivors with mobility challenges.
The ReStore system is comprised of a soft, garment-like design which connects to a lightweight waist pack and mechanical cables that help lift the patient's affected leg in synchronized timing with their natural walking pattern.
The patient wears the device in a waist pack, which holds two motors, each with a cable that goes down to the foot and ankle. The cables then extend to a foot...
Source: MDDI - June 5, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Motors & Motion Control Source Type: news
Financing Paves Way for Rapid to Enter the U.S. Market
Rapid Medical said it has raised $20 million in a series C round to give its IDE trial a boost. The Yokneam, Israel-based company is developing minimally invasive stroke treatment and protection products.
Rapid has been successfully enrolling patients in the TIGER IDE study in the U.S. since May of 2018.
In addition, the proceeds will be used to develop a commercial presence in the U.S. ahead of regulatory approvals, expanding the company's sales and marketing efforts in Europe, as well as the development of additional innovative products.
The financing round was led by JAM Capital Partners and MicroPort with participation...
Source: MDDI - April 23, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news
ReWalk Robotics files for exoskeleton suit clearance
ReWalk Robotics’ exo-suit designed for stroke rehabilitation.
ReWalk Robotics (NSDQ:RWLK) said it has applied to FDA for 510(k) clearance of its ReStore exoskeleton suit for gait training during stroke rehabilitation.
The Yokneam, Israel-based company designed its exo-suit to provide coordinated plantarflexion and dorsiflexion assistance to a patient’s foot and ankle. It recently won insurer reimbursement from Cigna and completed a clinical trial involving 44 patients at five rehabilitation centers in the U.S.
Get the full story on our sister site, Medical Design & Outsourcing.
The post ReWalk Robotics file...
Source: Mass Device - February 19, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: 510(k) Blog Business/Financial News Food & Drug Administration (FDA) Neurological News Well Regulatory/Compliance Robotics ReWalk Robotics Source Type: news
ReWalk Robotics shares fall on Q4, 2018 sales miss
Shares in ReWalk Robotics (NSDQ:RWLK) fell today after the rehabilitation exoskeleton maker posted fourth quarter and full year 2018 earnings that beat loss-per-share expectations but missed wide on sales consensus from Wall Street analysts.
The Yokneam, Israel-based company posted losses of approximately $5 million, or 10¢ per share, on sales of approximately $1.6 million for the three months ended December 31, seeing losses shrink 18.6% while sales grew 4.2% when compared with its fourth quarter during the previous year.
Losses per share were just ahead of the 14¢ consensus on Wall Street, where analysts expected too ...
Source: Mass Device - February 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat ReWalk Robotics Source Type: news
InspireMD inks distro deal for CGuard in South Africa
InspireMD (NYSE:NSPR) said today that it inked a deal with Torque Medical to distribute its CGuard Embolic Prevention System in South Africa.
The Israel-based company reported that it will begin the commercial launch for CGuard in South Africa immediately.
“We are extremely pleased with the opportunity to offer CGuard EPS in the South African market. We were approached by some of our key customers in the Vascular Surgery, Interventional Neurology and Interventional Cardiology field who had learned about CGuard EPS through conferences and publications and wanted us to make it available in South Africa,” Craig G...
Source: Mass Device - January 14, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Distribution Featured Vascular Wall Street Beat InspireMD Source Type: news
Neovasc touts Tiara TMVR success rate in study
A small study of the Neovasc (NSDQ:NVCN) Tiara transcatheter mitral valve replacement (TMVR) in high-risk patients revealed a 100% procedural success rate and immediate elimination of mitral regurgitation.
Published in Circulation: Cardiovascular Interventions, the study also showed no death, myocardial infarction, stroke, major bleeding, or access site complications at 30 days. The twelve patients in the study had had a previous aortic valve replacement. Such patients have been excluded from most TMVR trials because of the potential risks of left ventricular outflow tract obstruction or interaction between the TMVR anch...
Source: Mass Device - October 16, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Cardiac Implants Cardiovascular Featured Replacement Heart Valves Research & Development Mayo Clinic neovasc Neovasc Inc. Source Type: news
